Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys.
Özge BesciYağmur Damla AkçuraKübra Yüksek AcinikliGözde Akın KağızmanlıKorcan DemirEce BöberMustafa KirAyhan AbaciPublished in: Pediatric cardiology (2023)
Increased LVM, LVPWD, IVSD and Sm of patients receiving AI therapy in comparison to the control groups, and the significant correlations of these parameters with total testosterone and hemoglobin levels were determined as potential side effects of AIs. These findings emphasize the need of routine cardiac follow-up in patients using AIs.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- mental health
- young adults
- left ventricular
- prognostic factors
- risk factors
- artificial intelligence
- clinical practice
- replacement therapy
- stem cells
- risk assessment
- heart failure
- patient reported outcomes
- human health
- smoking cessation
- atrial fibrillation